MedTrace Logo

Fludrocortisone's Test in Salt Sensitivity

NCT01453959 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2011-10-21

No results posted yet for this study

Summary

The main hypothesis of this study is look for a clinical and fast test to identify salt sensitivity by administration of fludrocortisone.

Conditions

Interventions

DRUG

Fludrocortisone

Fludrocortisone in a dose of 0.4 mg/day for 7 days

OTHER

Diet cycles

Two cycle of diets: low salt diet(40mEq Sodium/day by 7 days) and high salt diet (240mEq Sodium/day by 7 days)

Sponsors & Collaborators

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

    lead OTHER_GOV

Principal Investigators

  • Decio Mion Junior, MD, PhD · General Hospital of School of Medicine - Universiy of Sao Paulo

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-09-30
Completion
2013-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01453959 on ClinicalTrials.gov